 Canadian marijuana titan Aurora Cannabis Inc. NASDAQ:ACB TSX:ACB together with 22nd Century Group, Inc. NASDAQ:XXII will license biosynthesis intellectual property to Cronos Group Inc. NASDAQ:CRON TSX:CRON. The licensed intellectual property is designed to help advance the research and development of the biosynthesis of cannabinoids. 